The Payer Exchange Podcast Episode 2: GERMANY - Detlev Parow on Obesity, Indication Pricing, and Gene Therapy Risk-Sharing
Listen and subscribe
In this episode of The Payer Exchange, Omar Ali speaks with Detlev Parow, former Head of Pharmaceutical Services at one of Germany’s largest statutory health insurance funds.
The conversation explores how Germany is responding to rising pressures on access and affordability—often in ways that differ from other major markets. From a pragmatic stance on obesity drugs to counterintuitive pricing dynamics for multi-indication products, Detlev offers sharp insights grounded in payer practice.
They also discuss the growing role of outcomes-based guarantees, especially for high-cost therapies like gene treatments, and reflect on how payer mindsets are adapting to evolving innovation and fiscal pressure.
“In Germany, multiple indications don’t always mean deeper discounts—sometimes they justify a better price.”
About The Payer Exchange
The Payer Exchange is a podcast from Verpora that explores how payers around the world are navigating complex pricing and access decisions. Hosted by Omar Ali, Verpora’s Head of Payers, each episode features a one-to-one conversation with a payer from a different healthcare system—offering direct insight into the practical realities of drug funding, reimbursement, and health system sustainability.
Listen and subscribe
Next Episode
E3 ITALY with Fabrizio Gianfrate →
Disclaimer: This presentation is for educational and informational purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this presentation may be reproduced for commercial purposes without the express permission of Verpora.
